These data suggest that anakinra causes changes in the subcutaneous tumour microenvironment, possibly via reduced IL-1B and TNF alpha signalling on endothelial cells preventing neo-angiogenesis and reducing nutrient/oxygen supply to the growing tumours. This evidence concerns the gene TNF and neoplasm.